What is GLP-1 microdosing?
A plain-language look at what GLP-1 microdosing means, why some providers favor lower doses for tolerability, and why a licensed provider decides what is appropriate for each person.
GLP-1 is short for glucagon-like peptide-1, a hormone your body makes that helps regulate appetite, blood sugar, and how quickly your stomach empties. Medications in the GLP-1 family work by mimicking this signal so the brain and gut respond more like they do after a meal. You may have heard the term microdosing used alongside these medications, and it is worth understanding what it actually means before assuming anything about it. This article explains the general idea in plain language and where a licensed provider fits in.
What microdosing means
Microdosing simply refers to using lower doses than the standard escalation schedules that come with brand-name products. Some providers take this approach to prioritize tolerability, meaning they hope to reduce the chance of common side effects like nausea while a person's body adjusts. It is important to be clear that microdosing is not an official, FDA-approved dosing protocol, and it is not a promise of any particular result. It is one clinical approach among several, and how a person responds can vary widely.
Not the brand-name products
Brand-name GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus are separate, FDA-approved products made by their respective manufacturers, and Medlly's product is not any of those brands. Medlly's versions are compounded, which means they are prepared by a pharmacy rather than mass-manufactured by the brand maker. Compounded medications are not FDA-approved, meaning they have not been evaluated by the FDA for safety, effectiveness, or quality. This is a meaningful distinction that any honest discussion should include.
About supportive ingredient stacks
You may also see GLP-1 approaches paired with supportive ingredients like NAD+ or vitamin B12, sometimes described as a stack. These are generally framed as supportive rather than central to how a GLP-1 works, and the evidence for what they add in this context is limited. They are not a substitute for the medication itself and they are not a guarantee of anything. Whether any of these are clinically appropriate is a decision for a provider, not a default add-on.
A provider decides
A licensed provider reviews your individual health information and decides whether any GLP-1 approach, dose, or supportive ingredient is clinically appropriate for you. Completing a consultation does not guarantee that you will receive a prescription, and that is by design, since these decisions are meant to be medical, not automatic. GLP-1 medications carry real risks and possible side effects, and they are not right for everyone. If you are curious, the responsible next step is an honest conversation with a provider who can weigh the full picture.
Explore glp-1 microdosing
See if provider-guided care is right for you.
